로딩 중…
지수 로딩 중…
SyntekaBio, Inc.
226330· KOSDAQ· Health Care· Health Care Equipment & Services
₩1,828+0.33%
2026-06-19
Price Chart
SyntekaBio, Inc.-71.70%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 44.34B KRW |
| Revenue | 2.98B KRW |
| Net Income | -207.4M KRW |
| Total Assets | 43.69B KRW |
| Net Assets | 28.34B KRW |
| Employees | 61 |
| Value | |
| P/B | 1.56x |
| P/S | 14.87x |
| FCF Yield | -24.04% |
| Profitability | |
| ROE | -0.73% |
| ROA | -0.47% |
| Op. Margin | -379.27% |
| Revenue Growth | -51.39% |
| Financial Health | |
| Debt Ratio | 154.18% |
| Total Debt | 7.77B KRW |
| FCF | -10.66B KRW |
| Cash | 13.40B KRW |
| Current Ratio | 1.16x |
| Performance | |
| 1Y Return | -71.70% |
| 1M Return | -22.21% |
| From 52W High | -73.84% |
| 1Y MDD | -73.80% |
| Trading | |
| Volume | 147,278 shares |
| Foreign Own. | 1.57% |
| Per Share | |
| EPS | -690 KRW |
| BPS | 1,168 KRW |
Company Info
Syntekabio, a bio venture established in 2009, became a research institute company in 2014, receiving dedicated supercomputing technology for genetic testing from ETRI. It offers AI new drug development platform services and a genomic big data platform, including NGS-ARS® precision medicine services, on a cloud basis. Leveraging an AI platform that integrates supercomputing and genomic big data technologies, Syntekabio focuses on innovating the new drug development process and developing new paradigm treatments. The company is headquartered in Yuseong-gu, Daejeon Metropolitan City.